pembrolizumab
Keytruda
Pharmaceutical company: Merck
NEW INDICATION & DOSAGE
International Federation of Gynecology and Obstetrics 2014 stage III to IVA cervical cancer in combination with chemoradiotherapy
Adults: 200-mg IV infusion every 3 weeks or 400-mg IV infusion every 6 weeks until disease progression or unacceptable toxicity occurs, or up to 24 months in patients without disease progression. Give before chemoradiotherapy when given on the same day.
Released: March 2024
Nursing Drug Handbook
© 2024 Wolters Kluwer
dupilumab
Dupixent
Pharmaceutical company: Sanofi and Regeneron Pharmaceuticals
NEW INDICATION & DOSAGE
Eosinophilic esophagitis
Children age 1 and older weighing at least 40 kg: 300 mg subcut once a week.
Children age 1 and older weighing 30 to less than 40 kg: 300 mg subcut every other week.
Children age 1 and older weighing 15 to less than 30 kg: 200 mg subcut every other week.
Released: March 2024
Nursing Drug Handbook
© 2024 Wolters Kluwer